February 9, 2025 - 00:26

In a heartfelt conversation at the 32nd Annual Movieguide Awards, Candace Cameron Bure shared insights about her longtime friend and 'Full House' co-star, Dave Coulier. She revealed that she frequently reaches out to Coulier, who is currently undergoing treatment for stage 3 non-Hodgkin lymphoma, a diagnosis he received in October 2024.
Bure expressed her admiration for Coulier's resilience during this challenging time, emphasizing that he remains optimistic and strong as he navigates his recovery journey. The support from friends and family has been crucial for Coulier, and Bure's regular check-ins serve as a reminder of their enduring bond.
As fans continue to rally behind him, Bure's updates bring a sense of hope and solidarity. The entertainment community stands united in sending positive thoughts and prayers for Coulier's health and well-being as he fights this battle with courage and determination.
November 18, 2025 - 22:34
Nexus Health Systems Welcomes New LeadershipNexus Health Systems has announced the appointment of Erin Cassidy as its new Chief Executive Officer. In her new role, Cassidy expressed her commitment to advancing the organization`s mission of...
November 18, 2025 - 09:54
Comprehensive Study Examines Keto Diet's Impact on DepressionIn a groundbreaking investigation into the ketogenic diet`s effects on mental health, researchers have synthesized findings from 50 studies conducted over the past six decades. This extensive...
November 17, 2025 - 23:24
Major Transition: UCare Transfers Health Contracts to Medica, Affecting 300,000 MinnesotansIn a significant development for healthcare in Minnesota, UCare has reached an agreement to transfer its health contracts to Medica, impacting over 300,000 residents. This transition marks a...
November 17, 2025 - 03:15
Promising Results from Breast Cancer Vaccine TrialIn a groundbreaking development, a small group of women with advanced breast cancer has shown remarkable resilience after participating in a clinical trial for a new vaccine. All participants in...